Microbix Biosystems announces initiation of normal course issuer bid

Microbix Biosystems (MBXBF) announces the initiation of a Normal Course Issuer Bid program for the repurchase and cancellation of outstanding common shares. Specifically, the NCIB enables Microbix to repurchase up to 6,949,346 Common Shares, that number being approximately five percent of the 138,986,931 Shares outstanding as at November 26, 2025. Repurchases will be made through the facilities of the Toronto Stock Exchange and alternative trading systems over a 12-month period starting on December 9, 2025 and the NCIB will end on December 8, 2026 or such earlier date as the Company completes its purchases pursuant to the NCIB or provides notice of termination. The actual number of Shares which may be repurchased pursuant to the NCIB will be determined by management under applicable rules and policies.